Approximately 70% of patients who experience initial nausea report complete symptom resolution without dose reduction or medication discontinuation
Webster AN, Becker JJ, Li C, Schwalbe DC, Kerspern D, Karolczak EO, Bundon CB, Sun H, Hao Y, Liu H, Gao F (2025) The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment
We and others have demonstrated that GLP-1R signalling elevated ATP levels 38, 39 , strengthening the hypothesis that the incretin hormone may promote -cell function through regulation of energy metabolism, especially considering the central role that ATP generation and an increase in ATP/ADP ratio play during GSIS
A GLP-1 medication makes the calorie deficit easier to sustain